Pharmacological Evaluation of Synthetic Dominant-Negative Peptides Derived from the Competence-Stimulating Peptide of Streptococcus pneumoniae.
Pharmacological Evaluation of Synthetic Dominant-Negative Peptides Derived from the Competence-Stimulating Peptide of Streptococcus pneumoniae.
复制标题
肺炎链球菌活性刺激肽合成的显性负肽的药理学评价。
DOI:
10.1021/acsptsci.2c00037
复制
发表时间:
2022
影响因子:
--
通讯作者:
Lau,GeeW
中科院分区:
文献类型:
--
作者:
Oh,MyungWhan;Lella,Muralikrishna;Kuo,ShannyHsuan;Tal-Gan,Yftah;Lau,GeeW
The competence regulon ofStreptococcus pneumoniae(pneumococcus) is a quorum-sensing circuitry that regulates the ability of this pathogen to acquire antibiotic resistance or perform serotype switching, leading to vaccine-escape serotypes, via horizontal gene transfer, as well as initiate virulence. Induction of the competence regulon is centered on binding of the competence-stimulating peptide (CSP) to its cognate receptor, ComD. We have recently synthesized multiple dominant-negative peptide analogs capable of inhibiting competence induction and virulence inS. pneumoniae. However, the pharmacodynamics and safety profiles of these peptide drug leads have not been characterized. Therefore, in this study, we compared the biostability of cyanine-7.5-labeled wild-type CSPs versus dominant-negative peptide analogs (dnCSPs) spatiotemporally by using an IVIS Spectrumin vivoimaging system. Moreover,in vitrocytotoxicity andin vivotoxicity were evaluated. We conclude that our best peptide analog, CSP1-E1A-cyc(Dap6E10), is an attractive therapeutic agent against pneumococcal infection with superior safety and pharmacokinetics profiles.